News

Chicago, Illinois July 8, 2025 – Cure CMT, a leading advocacy organization dedicated to finding treatments and cures for Charcot-Marie-Tooth disease, today announced a significant partnership with Tamarack Habilitation Technologies, Inc., a Minnesota-based leader in orthotic and prosthetic innovation. Through this collaboration, Tamarack has provided a generous investment to support Cure CMT’s mission while making their advanced orthotic products directly accessible to CMT patients through Cure CMT’s website platform.

Charcot-Marie-Tooth disease affects approximately 1 in 2,500 people worldwide, causing progressive muscle weakness and foot drop that significantly impacts mobility and daily living. Many individuals with CMT require ankle-foot orthoses (AFOs) to maintain their independence and quality of life.

“This partnership represents a meaningful step forward in our commitment to connecting CMT patients with the tools and technologies they need to live their fullest lives,” said Pat Livney, Founder at Cure CMT. “Tamarack’s innovative approach to orthotic design aligns perfectly with our mission to enhance quality of life for individuals living with CMT.”

Tamarack, which has been developing cutting-edge orthotic and prosthetic solutions since 1990, brings three decades of expertise in creating more comfortable and effective bracing solutions. Their proprietary flexure joint technology has revolutionized AFO design, offering CMT patients improved stability, reduced fatigue, and enhanced functionality in their mobility devices.

“Our mission has always been to improve and maximize human performance and comfort,” said Cole Carson, Owner and CEO at Tamarack. “Partnering with Cure CMT allows us to directly serve a community that can significantly benefit from our advanced orthotic technologies. We’re proud to support both their advocacy work and their efforts to connect patients with life-changing mobility solutions.”

Through this partnership, CMT patients will gain streamlined access to Tamarack’s specialized orthotic components through Cure CMT’s website, eliminating barriers that often exist between patients and advanced assistive technologies. The collaboration also supports Cure CMT’s broader educational and research initiatives through Tamarack’s financial contribution.

The partnership underscores both organizations’ shared commitment to innovation, accessibility, and improving outcomes for individuals with mobility challenges. As CMT research continues to advance, ensuring patients have access to the best available supportive technologies remains crucial for maintaining independence and quality of life.